Literature DB >> 10627301

Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model.

J Shi1, S H Yang, L Stubley, A L Day, J W Simpkins.   

Abstract

Silent stroke is one of the risk factors of dementia. In the present study, we used a novel focal ischemic animal model to investigate the effects of comparatively small changes of cerebral blood flow (CBF) on the expression of beta-amyloid precursor protein (APP) mRNA. Focal ischemia was achieved by introducing a 4-0 monofilament to the bifurcation of anterior and middle cerebral arteries. Brain samples were harvested from ischemic core and penumbra of cortices at 1, 4 and 7 days following ischemia. The expression of APP mRNA was assessed by RT-PCR. The CBF was decreased to 50% for 1 day after stroke and recovered to 90% at the fourth day after stroke. The changes of CBF were accompanied by an increase in the expression of APP mRNA. APP mRNA increased to 208% and 152% in the penumbra and core ischemic regions, respectively, on the fourth day after MCAO and remained high through the seventh day of ischemia. This study suggests brain hypoperfusion enhances APP mRNA expression and may contribute to the progression of cognitive impairment after silent stroke.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10627301     DOI: 10.1016/s0006-8993(99)02113-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  48 in total

1.  Links between the pathology of Alzheimer's disease and vascular dementia.

Authors:  Marcin Sadowski; Joanna Pankiewicz; Henrieta Scholtzova; Yong-sheng Li; David Quartermain; Karen Duff; Thomas Wisniewski
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

2.  Blood pressure and dementia - a comprehensive review.

Authors:  Sean P Kennelly; Brian A Lawlor; Rose Anne Kenny
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

3.  Effect of ischemic neuronal insults on amyloid precursor protein processing.

Authors:  Phil Hyu Lee; Eun Mi Hwang; Hyun Seok Hong; Jung Hyun Boo; Inhee Mook-Jung; Kyoon Huh
Journal:  Neurochem Res       Date:  2006-06-21       Impact factor: 3.996

4.  Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI.

Authors:  Chandan Misra; Yong Fan; Christos Davatzikos
Journal:  Neuroimage       Date:  2008-11-05       Impact factor: 6.556

5.  Pyrrolidine dithiocarbamate attenuates brain Aβ increase and improves long-term neurological outcome in rats after transient focal brain ischemia.

Authors:  Jiejie Li; Wenli Sheng; Chenzhuo Feng; Zhiyi Zuo
Journal:  Neurobiol Dis       Date:  2011-09-24       Impact factor: 5.996

6.  Flavanols, mild cognitive impairment, and Alzheimer's dementia.

Authors:  Ami K Patel; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Med       Date:  2008-04-15

7.  Reduced early hypoxic/ischemic brain damage is associated with increased GLT-1 levels in mice expressing mutant (P301L) human tau.

Authors:  Guanghong Liao; Miou Zhou; Simon Cheung; James Galeano; Nam Nguyen; Michel Baudry; Xiaoning Bi
Journal:  Brain Res       Date:  2008-11-01       Impact factor: 3.252

8.  UV irradiation accelerates amyloid precursor protein (APP) processing and disrupts APP axonal transport.

Authors:  Angels Almenar-Queralt; Tomas L Falzone; Zhouxin Shen; Concepcion Lillo; Rhiannon L Killian; Angela S Arreola; Emily D Niederst; Kheng S Ng; Sonia N Kim; Steven P Briggs; David S Williams; Lawrence S B Goldstein
Journal:  J Neurosci       Date:  2014-02-26       Impact factor: 6.167

Review 9.  Contribution of hypoxia to Alzheimer's disease: is HIF-1alpha a mediator of neurodegeneration?

Authors:  O O Ogunshola; X Antoniou
Journal:  Cell Mol Life Sci       Date:  2009-09-11       Impact factor: 9.261

10.  Effects of ATP sensitive potassium channel opener on the mRNA and protein expressions of caspase-12 after cerebral ischemia-reperfusion in rats.

Authors:  Hong Zhang; Li-Chun Song; Chun-Hong Jia; Yong-Li Lu
Journal:  Neurosci Bull       Date:  2008-02       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.